Additionally, loss of muscle mass during rapid weight loss can reduce the efficiency of muscle pumps that help return blood from the extremities to the heart, leading to blood stasis, particularly in the legs, which is a risk factor for deep vein thrombosis (DVT)
Others experience a more variable pattern with periods of faster loss followed by temporary plateaus
[1] [2] Tirzepatide (Mounjaro, Zepbound) is a dual GIP/GLP-1 receptor agonist with similar clinical effects
Her research focuses on improving the treatment of obesity in medical settings and addressing weight stigma
Managing the Transition Period To make the switch as smooth as possible, we recommend a proactive approach to your health
Users can experience not just nausea and flushing, but also appetite loss, increased libido, and sometimes fatigue